Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 4, 2008, Pages 699-706

  Rogers, Danny ^a   Nylander, Karen D ^b   Mi, Zhiping ^a   Hu, Tong ^a   Schor, Nina F ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CASPASE 3; COMPLEMENTARY DNA; ENEDIYNE; PLASMID VECTOR; PROTEIN BCL 2; PROTEIN BNIP3; ZINOSTATIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MEDULLOBLASTOMA; MOLECULAR CLONING; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MEDULLOBLASTOMA; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; ZINOSTATIN;

EID: 47549086151     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0725-7     Document Type: Article

References (49)

1. C Bartholomeusz H Itamochi LX Yuan 2005 Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model Cancer Res 65 8406 8413
2. JA Bush G Li 2003 The role of Bcl-2 family members in the progression of cutaneous melanoma Clin Exp Metastasis 20 531 539
3. MI Del Principe G Del Poeta L Maurillo 2003 P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia Br J Haematol 121 730 738
4. DA Fennell 2003 Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer Clin Lung Cancer 4 307 313
5. S Hopkins-Donaldson R Cathomas AP Simoes-Wust 2003 Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment Int J Cancer 106 160 166
6. PJ Real A Sierra A De Juan 2002 Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 21 7611 7618
7. CJ Zhu YB Li MC Wong 2003 Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells J Neurosci Res 74 60 66
8. M Cortazzo NF Schor 1996 Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2 Cancer Res 56 1199 1203
9. Z Mi B Hong ZK Mirnics 2006 Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2 Cancer Chemother Pharmacol 57 357 367
10. NF Schor YY Tyurina JP Fabisiak 1999 Selective oxidation and externalization of membrane phosphatidylserine: Bcl-2-induced potentiation of the final common pathway for apoptosis Brain Res 831 125 130
11. NF Schor CM Rudin AR Hartman 2000 Cell line dependence of Bcl-2-induced alteration of glutathione handling Oncogene 19 472 476
12. DJ Kane TA Sarafian R Anton 1993 Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species Science 262 1274 1277
13. Y Liang KD Nylander C Yan 2002 Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2 Mol Pharmacol 61 142 149
14. TL Hartsell JC Yalowich MK Ritke 1995 Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin J Pharmacol Exp Ther 275 479 485
15. NF Schor YY Tyurina VA Tyurin 1999 Differential membrane antioxidant effects of immediate and long-term estradiol treatment of MCF-7 breast cancer cells Biochem Biophys Res Commun 260 410 415
16. DA Tweddle AJ Malcolm M Cole ADJ Pearson J Lunec 2001 p53 cellular localization and function in neuroblastoma Am J Pathol 158 2087 2077
17. JA Cerrato WK Yung TJ Liu 2001 Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis Neuro Oncol 3 113 122
18. RC Castellino M De Bortoli X Lu 2007 Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D J Neuro-oncol 86 245 256
19. Ramnath V, Rekha PS, Kuttan G, Kuttan R (2007) Regulation of caspase-3 and Bcl-2 expression in Dalton's lymphoma ascites cells by abrin. Evid-based Complement Alter Med (e-pub). doi:10.1093/ecam/nem099
20. American Cancer Society (2007) What are the key statistics for brain and spinal cord tumors? http://www.cancer.org/docroot/CRI/content/ CRI_2_4_1X_What_are_the_key_statistics_for_brain_and_spinal_cord_tumors_3.asp? sitearea=
21. D Jenkin M Greenberg H Hoffman 1995 Brain tumors in children: long-term survival after radiation treatment Int J Radiat Oncol Biol Phys 31 445 451
22. GM Haase C Perez JB Atkinson 1999 Current aspects of biology, risk assessment, and treatment of neuroblastoma Semin Surg Oncol 16 91 104
23. SJ Cotterill AD Pearson J Pritchard 2000 Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992 Eur J Cancer 36 901 908
24. M Dole G Nunez AK Merchant 1994 Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma Cancer Res 54 3253 3259
25. MG Dole R Jasty MJ Cooper 1995 Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis Cancer Res 55 2576 2582
26. L Campos JP Rouault O Sabido 1993 High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy Blood 81 3091 3096
27. S Nakasu Y Nakasu H Nioka 1994 Bcl-2 protein expression in tumors of the central nervous system Acta Neuropathol 88 520 526
28. C Teixeira JC Reed MA Pratt 1995 Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells Cancer Res 55 3902 3907
29. A Bonetti M Zaninelli F Pavanel 1996 Bcl-2 expression is associated with resistance to chemotherapy in advanced breast cancer Proc Am Assoc Cancer Res 37 192
30. AW TJ Beham McDonnell 1996 Bcl-2 confers resistance to androgen deprivation in prostate carcinoma cells Proc Am Assoc Cancer Res 37 224
31. Y Tu S Renner F Xu 1998 BCL-X expression in multiple myeloma: possible indicator of chemoresistance Cancer Res 58 256 262
32. NW van de Donk O de Weerdt G Veth 2004 G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma Leukemia 18 1078 1084
33. J Williams PC Lucas KA Griffith 2005 Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease Gynec Oncol 96 287 295
34. PM Ganigi V Santosh B Anandh 2005 Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients Pediatr Neurosurg 41 292 299
35. H Albrecht J Tschopp CV Jongeneel 1994 Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF FEBS Lett 351 45 48
36. YY Tyurina VA Tyurin G Carta 1997 Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells Arch Biochem Biophys 344 413 423
37. Y Liang ZK Mirnics C Yan 2003 Bcl-2 mediates induction of neural differentiation Oncogene 22 5515 5518
38. C Friesen Y Kiess KM Debatin 2004 A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells Cell Death Differ 11 Suppl 1 S73 85
39. Q Chen YC Chai S Mazumder 2003 The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction Cell Death Differ 10 323 334
40. YY Tyurina KD Nylander ZK Mirnics 2005 The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress Aging Cell 4 187 196
41. J Yang X Liu K Bhalla 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked Science 275 1129 1132
42. RM Kluck E Bossy-Wetzel DR Green 1997 The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 275 1132 1136
43. A Baker BD Santos G Powis 2000 Redox control of caspase-3 activity by thioredoxin and other reduced proteins Biochem Biophys Res Commun 268 78 81
44. TL Hartsell LM Hinman PR Hamann 1996 Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage J Pharmacol Exp Ther 277 1158 1166
45. TA Beerman R Poon IH Goldberg 1977 Single-strand nicking of DNA in vitro by neocarzinostatin and its possible relationship to the mechanism of drug action Biochim Biophys Acta 475 294 306
46. WG DeGraff JB Mitchell 1985 Glutathione dependence of neocarzinostatin cytotoxicity and mutagenicity in Chinese hamster V-79 cells Cancer Res 45 4760 4762
47. NF Schor 1992 Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells J Clin Invest 89 774 781
48. A Samali B Zhivotovsky DP Jones 1998 Detection of pro-caspase-3 in cytosol and mitochondria of various tissues FEBS Lett 431 167 169
49. Y Liang C Yan NF Schor 2001 Apoptosis in the absence of caspase 3 Oncogene 20 6570 6578